InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
12
T+90 hit rate
100%
T+90 mean return
+16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Gassert Chad, SVP, Développement Corporatif et Stratégie. Director active across 1 company, notably ANI Pharmaceuticals INC. In total, 24 reports have been published. Breakdown: 1 buy · 12 sells. Total volume traded: €13.9m. Activity tracked since 18 March 2022. The latest transaction was disclosed on 26 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gassert Chad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
11,116 shares@ US$77.154.8% of flowCommon StockSEC:0001871002-26-000006:0
1,608 shares@ US$76.700.9% of flowCommon StockSEC:0001871002-26-000004:0
1,717 shares@ US$77.361.0% of flowCommon StockSEC:0001871002-26-000004:1
4,269 shares@ US$76.251.8% of flowCommon StockSEC:0001871002-26-000002:0
14,642 shares@ US$89.077.9% of flowCommon StockSEC:0001871002-25-000007:0
20,000 shares@ US$86.9711.4% of flowCommon StockSEC:0001871002-25-000004:0
14,362 shares0Common StockSEC:0001871002-25-000002:0
9,574 shares0Common StockSEC:0001871002-25-000002:1
20,000 shares@ US$63.4410.2% of flowCommon StockSEC:0001871002-24-000014:0
20,000 shares@ US$64.4110.2% of flowCommon StockSEC:0001871002-24-000012:0
20,000 shares@ US$66.6210.7% of flowCommon StockSEC:0001871002-24-000010:0
20,000 shares@ US$67.2510.8% of flowCommon StockSEC:0001871002-24-000008:0
20,000 shares@ US$65.8110.4% of flowCommon StockSEC:0001871002-24-000006:0
1,635 shares@ US$67.670.9% of flowCommon StockSEC:0001871002-24-000004:0
13,421 shares0Common StockSEC:0001871002-24-000002:0
20,000 shares@ US$56.489.3% of flowCommon StockSEC:0001871002-23-000009:0
20,000 shares@ US$64.7010.3% of flowCommon StockSEC:0001871002-23-000006:0
20,000 shares@ US$51.068.0% of flowCommon StockSEC:0001871002-23-000004:0
20,000 shares@ US$53.438.4% of flowCommon StockSEC:0001104659-23-078742:0
20,000 shares@ US$51.328.1% of flowCommon StockSEC:0001104659-23-074398:0
17,369 shares0Common StockSEC:0001104659-23-041729:0
11,578 shares0Common StockSEC:0001104659-23-041729:1
5,000 shares@ US$27.14880.8% of flowCommon StockSEC:0001415889-22-003267:0
Canonical exit: 16 Jun 2022 (T+90)
383,226 sharesCommon StockSEC:0001415889-21-005442:0
24 of 24 declarations
About Gassert Chad
Gassert Chad is SVP, Corporate Development and Strategy at ANI Pharmaceuticals INC (XNAS). He has 24 filings in total, and among the recent filings available between 2021-11-23 and 2026-03-02, the reported amounts are 122297 in buys and 13793803 in sells, with the modal transaction nature indicated as Sale.
